drugset

drugset / Trial / NCT06222034

Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)

NCT06222034 ↗

Phase 1 Terminated 9 enrolled Alfasigma S.p.A.

Non-randomizedParallel-groupOpen-labelTreatment

Summary

A Study to evaluate the pharmacokinetics, safety, and tolerability in paediatric population for treating juvenile idiopathic arthritis (JIA).

Timeline

Start: 2024-05-13
Primary completion: 2026-06-17
Completion: 2026-06-17

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Filgotinib	Small molecule	—	Oral

Indications